Fredun Pharmaceuticals has launched ‘DAULCEL’, its premium wellness and longevity-focused brand developed to cater to the growing demand for preventive healthcare, healthy aging, and lifestyle-oriented wellness solutions. The launch marks another strategic step in its expansion into innovation-led and future-focused healthcare segments.
DAULCEL is positioned as a premium wellness platform centered on quality, innovation, and evolving consumer wellness needs. The brand is aimed at addressing the increasing global focus on vitality, wellness optimization, recovery-focused healthcare, and long-term healthy living through science-oriented wellness solutions.
The initiative complements Fredun Pharmaceuticals’ existing pharmaceutical and healthcare capabilities while creating new opportunities within specialized wellness and longevity-driven categories. The launch also reflects the company’s continued focus on building a diversified and future-ready healthcare portfolio
Fredun Pharmaceuticals is engaged in manufacturing of pharmaceutical products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1800.65 |
| Dr. Reddys Lab | 1277.05 |
| Cipla | 1372.75 |
| Zydus Lifesciences | 1078.40 |
| Lupin | 2277.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: